Full text
PDFPage 1424
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Crossley I. R., Williams R. Progress in the treatment of chronic portasystemic encephalopathy. Gut. 1984 Jan;25(1):85–98. doi: 10.1136/gut.25.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Greenberg L. H., Momary H. Audiotoxicity and nephrotoxicity due to orally administered neomycin. JAMA. 1965 Nov 15;194(7):827–828. [PubMed] [Google Scholar]
- KUNIN C. M., CHALMERS T. C., LEEVY C. M., SEBASTYEN S. C., LIEBER C. S., FINLAND M. Absorption of orally administered neomycin and kanamycin with special reference to patients with severe hepatic and renal disease. N Engl J Med. 1960 Feb 25;262:380–385. doi: 10.1056/NEJM196002252620802. [DOI] [PubMed] [Google Scholar]
- Kavanagh K. T., McCabe B. F. Ototoxicity of oral neomycin and vancomycin. Laryngoscope. 1983 May;93(5):649–653. doi: 10.1002/lary.1983.93.5.649. [DOI] [PubMed] [Google Scholar]
- Matzke G. R., Halstenson C. E., Olson P. L., Collins A. J., Abraham P. A. Systemic absorption of oral vancomycin in patients with renal insufficiency and antibiotic-associated colitis. Am J Kidney Dis. 1987 May;9(5):422–425. doi: 10.1016/s0272-6386(87)80146-4. [DOI] [PubMed] [Google Scholar]
- Matzke G. R., Zhanel G. G., Guay D. R. Clinical pharmacokinetics of vancomycin. Clin Pharmacokinet. 1986 Jul-Aug;11(4):257–282. doi: 10.2165/00003088-198611040-00001. [DOI] [PubMed] [Google Scholar]
- Thompson C. M., Jr, Long S. S., Gilligan P. H., Prebis J. W. Absorption of oral vancomycin - possible associated toxicity. Int J Pediatr Nephrol. 1983 Mar;4(1):1–4. [PubMed] [Google Scholar]